Cargando…

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season

In accordance with European directives, each year the enhanced safety surveillance (ESS) of seasonal influenza vaccines should be conducted in order to detect any potential increase in reactogenicity when the vaccine composition is updated or a new formulation becomes available. The objective of thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amicizia, Daniela, Domnich, Alexander, Lai, Piero Luigi, Orsi, Andrea, Icardi, Giancarlo, Tkach-Motulyak, Oksana, Panatto, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Influenza
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072113/ https://www.ncbi.nlm.nih.gov/pubmed/36919537 http://dx.doi.org/10.1080/21645515.2023.2190279

Ejemplares similares

Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine
por: Domnich, Alexander, et al.
Publicado: (2023)

Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59(®)‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons
por: Panatto, Donatella, et al.
Publicado: (2019)

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults
por: Frey, Sharon S., et al.
Publicado: (2023)

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
por: Wei, Xia, et al.
Publicado: (2023)

Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50–64 Years of Age
por: Poder, Airi, et al.
Publicado: (2023)

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany
por: Kohli, Michele A., et al.
Publicado: (2022)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

AS03- and MF59-Adjuvanted Influenza Vaccines in Children
por: Wilkins, Amanda L., et al.
Publicado: (2017)

COVID-19 and Seasonal Influenza Vaccination: Cross-Protection, Co-Administration, Combination Vaccines, and Hesitancy
por: Domnich, Alexander, et al.
Publicado: (2022)

Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
por: Villa, Marco, et al.
Publicado: (2013)

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
por: Tsai, Theodore F
Publicado: (2013)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Efficient simulation of the spatial transmission dynamics of influenza
por: Tsai, Meng-Tsung, et al.
Publicado: (2010)

Tempo and Mode in the Molecular Evolution of Influenza C
por: Gatherer, Derek
Publicado: (2010)

Absolute Humidity and the Seasonal Onset of Influenza in the Continental US
por: Shaman, Jeffrey, et al.
Publicado: (2010)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
por: Bianculli, Pablo Manuel, et al.
Publicado: (2022)

Projection of seasonal influenza severity from sequence and serological data
por: Wolf, Yuri I, et al.
Publicado: (2010)

Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities
por: Dalziel, Benjamin D., et al.
Publicado: (2018)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions
por: Truscott, James, et al.
Publicado: (2010)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment
por: Calabrò, Giovanna Elisa, et al.
Publicado: (2022)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom
por: Ghani, Azra, et al.
Publicado: (2010)

PREVALENCE OF ANTIBODIES AGAINST INFLUENZA VIRUS IN NON-VACCINATED EQUINES FROM THE BRAZILIAN PANTANAL
por: Silva, Lucas Gaíva E, et al.
Publicado: (2014)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Can Reactive School Closures help critical care provision during the current influenza pandemic?
por: House, Thomas, et al.
Publicado: (2009)

Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere
por: Nolting, Jacqueline, et al.
Publicado: (2012)

Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic
por: Hoffman, Brian L.
Publicado: (2011)

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.
por: Athanasiou, Maria, et al.
Publicado: (2010)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

Age-Related Differences in the Accuracy of Web Query-Based Predictions of Influenza-Like Illness
por: Domnich, Alexander, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_iv1shc44i8sjm1b62jcdeiahvv